Clinical Nutrition Market Drivers, Opportunities, and Trends in Coming Years

1
Clinical Nutrition Market Size, Trends, Growth
Opportunities post after COVID19 Outbreak
PSIntelligence.Allrightsreserved 1
2
The global clinical nutrition market was valued
at 39,339.4 million in 2015, and it is expected
to grow at a CAGR of 5.4 during 2016 2022.
The factors driving the growth of the global
market include increasing geriatric population,
high birth rate and high number of premature
birth, surge in the number of victims of
malnutrition receiving treatment, surging
incidence of lifestyle associated disease, and
increasing incidence of cancer and central
nervous system diseases. Malnutrition is a
widespread problem, affecting the lives of
millions of people globally. It is a condition
that occurs due to deficiency of essential
nutrients in the body. In 2010, around 40 of all
hospital patients globally were malnourished.
Clinical nutrition is the most efficient way to
treat malnutrition and helps in avoiding
associated costs. In Europe, around one-third of
all hospital patients were malnourished in 2012.
The increase in the number of victims of
malnutrition globally, is expected to result in
an increased usage of healthcare resource due to
the longer stays in hospitals. As per an article
of 2012, the malnutrition cost European
government up to USD 237.0 billion a year while
the clinical nutrition accounted for about 2.5
of the cost involved with malnutrition. The
increasing incidence of cancer and central
nervous system (CNS) diseases is driving the
growth of the global enteral nutrition market.
Enteral nutrition products are considered to be
one of the best alternatives during the
treatment of cancer and CNS diseases, to avoid
nutrition deficiency in human body, for optimal
functioning of various organs. Cancer can change
the metabolism of nutrient uptake in patients
body, therefore they require good nutrition.
Cancer may lead to malnutrition and weight loss
therefore, patients are required continuous
nutrient feeding. Enteral nutrition is one of the
best solutions to the problem. According to the
WHO, there were 14.1 million new cancer cases,
8.2 million cancer deaths and 32.6 million
people living with cancer (within 5 years of
diagnosis) in 2012 globally. The organization
also reported that 57 (8 million) of new cancer
cases, 65 (5.3 million) of the cancer deaths and
48 (15.6 million) of the 5-year prevalent
cancer cases occurred in the less developed
regions. Request to Get the Sample Report_at_
https//www.psmarketresearch.com/market-analysis/c
linical- nutrition-market/report-sample In
2015, Asia-Pacific held the largest share in the
global clinical nutrition market with 40.4
share. The region is anticipated to witness
rapid growth during the forecast period. The
increasing birth rate, along with growing
geriatric population and high number of people
with malnutrition is driving the growth of the
clinical nutrition market in the region. The
total number of people aged 65 years and above
in Asia-Pacific was estimated at 288.0 million in
2010. This number is expected to reach 911.0
million by 2050. Additionally, the increasing
number of malnutrition treatment cases in the
region is expected to increase the demand for
clinical nutrition products. Moreover, with the
increasing disposable income, increasing
healthcare expenditure, and increasing awareness
regarding nutrition is anticipated to fuel the
growth of the Asia-Pacific clinical nutrition
market. The different governments in the region
are running awareness programs throughout these
countries to encourage people for consuming
nutritional diet. This would indirectly support
the growth of the clinical nutrition market in
the region. Make Enquiry Before Buying the
Report_at_ https//www.psmarketresearch.com/send-
enquiry?enquiry-urlclinical-nutrition-market
3

• Some of the major players operating in the global
  clinical nutrition market include Baxter
  International Inc., Abbott Laboratories, B. Braun
  Melsungen AG, Nestlé S.A., Groupe Danone, Mead
  Johnson Nutrition Company, Fresenius Kabi AG, and
  Perrigo Company Plc.
• GLOBAL CLINICAL NUTRITION MARKET
• By Product Infant nutrition, enteral nutrition
  and parenteral nutrition
• By Region North America, Europe, Asia-Pacific,
  South America, and Middle East and Africa
• GLOBAL CLINICAL NUTRITION MARKET, BY PRODUCT
• Global Infant Nutrition Market
• By Product Milk-based, soy-based, organic,
  probiotic / prebiotic, others
• By Region
• Global Enteral Nutrition Market
• By Product Standard and enteral nutrition for
  chronic illness
• By Region
• Global Parenteral Nutrition Market
• By Product Amino acids, dextrose, fats and
  additives
• By Region
• This study covers

PSIntelligence.Allrightsreserved
3
4
Disclaimer PS Intelligence always keeps its
customers interests at the core while carrying
out research activities. PS Intelligence
ensures the reliability and accuracy of
information and data provided in its market
research publications. However, the information
in publications is subject to fluctuations, as
it is based on primary interviews of officials
from various companies or organizations. PS
Intelligence is not responsible for any
incorrect data provided by the key industry
players of the concerned domain. The information
or analysis in PS Intelligence publications
represents opinions based on research and should
not be interpreted as statements of fact.
Information in this report was believed to be
correct at the time of publication, but cannot be
guaranteed. PS Intelligence does not endorse
any product, service, or vendor depicted in its
research publications. All intellectual
properties, including trademarks and copyrights,
belong to their respective owners and may be
protected by copyright. Under no circumstance can
these be reproduced in any form without prior
written agreement of their owners. An order for
market research report is intended for internal
use of the company only and not for disclosure
to third parties or any other publication in
general. No service, report, or part thereof
provided by PS Intelligence can be reproduced,
republished, resold, revealed, distributed,
circulated, or sublicensed in any medium or form
now realized or hereafter become realized,
including but not limited to, all forms of
optical-based media, magnetic, electronic, or
digital, without a written permission from
Prescient Strategic Intelligence Pvt. Ltd.
5
Kindly write to enquiry_at_psmarketresearch.com
B-13, Sector 2, Noida, U.P. 201301,
INDIA Contact No 91 120 4541 337 US/Canada
Toll-Free 1-888-778-7886
4
PSIntelligence.Allrightsreserved